Every parent aspires to nurture life and to cradle their bundle of joy. Yet some parents meet with unforeseen hurdles on this path that test their determination and make them rethink their paths. Within this landscape, the donor egg IVF (in-vitro fertilization) emerges as the torchbearer of opportunities, presenting an avenue to parenthood. The intensified public discussion, awareness campaign, and media exposure aid in curbing the stigma surrounding infertility treatments, encouraging individuals to seek help.
Recent revisions in market analysis indicate an amplification in demand for donor egg IVF (in-vitro fertilization) are accounted for the forecast valuation of US$ 3,347.10 million in 2024. Sales of donor egg IVF (in-vitro fertilization) are proficient to attain the worth and strike US$ 7,159.50 million by 2034 as these trends gain momentum and become prevalent. This portrays a robust 7.90% CAGR between 2024 and 2034.
| Attributes | Details |
|---|---|
| Donor Egg IVF (In-Vitro Fertilization) Market Value for 2024 | US$ 3,347.10 million |
| Donor Egg IVF (In-Vitro Fertilization) Market Value for 2034 | US$ 7,159.50 million |
| Donor Egg IVF (In-Vitro Fertilization) Market CAGR from 2024 to 2034 | 7.90% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As the world witnesses couples delaying their first pregnancy which leads to a prevalence of infertility issues, it is proven that treatments such as in-vitro fertilization (IVF) and more advanced processes like donor egg IVF have the potential for skyrocketing demand.
It has been verified in numerous researches that the number of women with ovaries that have untimely ceased to function has escalated over the recent past. This infers that the donor egg sustains the opportunity for them to conceive and lead a successful pregnancy. The strengthening infertility burden brings along a robust upswing in female egg donors, which is referenced as a vital stimulus to augment prospects of the donor egg IVF market.
| Attributes | Details |
|---|---|
| Market Value for 2019 | US$ 2,172.40 million |
| Market Value for 2023 | US$ 7,159.50 million |
| Market CAGR from 2019 to 2023 | 7.40% |
The categorized donor egg in-vitro fertilization market analysis is included in the preceding subsection. Based on comprehensive studies, the fresh donor egg cycle sector controls the cycle type category. Likewise, fertility clinics and IVF centers segment top the end-user category.
| Segment | Fertility Clinics and IVF Centers |
|---|---|
| Share (2024) | 64.50% |
Fertility clinics and IVF centers cater to specialization and exhaustive services customized for patients seeking donor egg IVF, alluring a continuous stream of patients. Patients look for the tailored care and attention provided by fertility clinics and IVF centers, nurturing their trust and loyalty towards them.
The success stories linked to the prominent fertility clinics and IVF centers attract patients looking for powerful solutions to their fertility roadblocks. The association of medical professionals and specialists within fertility clinics and IVF centers strengthens the patient experience and adds to the supremacy of this segment.
| Segment | Fresh Donor Egg Cycle |
|---|---|
| Share (2024) | 70.10% |
Demand for fresh donor egg cycle segments remains sturdy despite the progression in frozen egg preservation technologies. The fresh donor egg cycle bestows a more natural process, corresponding to patient alternatives.
The strengthening versatility in scheduling and reduced waiting times captivate more patients to fresh cycles. The fresh donor egg cycle imparts immediate solutions that align with the patient's zeal for urgency and the emotional aspect of starting a family. This suggests that there is soaring traction toward the fresh donor egg cycle segment.
Principal Consultant
The donor egg IVF (In-Vitro Fertilization) market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for donor egg in-vitro fertilization.
Demand Analysis of Donor Egg IVF Service in North America
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 7.80% |
| Canada | 5.80% |
The United States exhibits innovative healthcare facilities and a strong regulatory infrastructure, warranting premium donor egg in-vitro fertilization procedures. The innovative technologies integrated with reimbursement policies assist the upsurge in the demand for donor egg IVF treatments in the United States. The amplifying donor egg in-vitro fertilization service demand in the United States is prompted by delayed childbearing, escalating infertility rates, and transitioning societal ethics.
Along with the presence of pre-eminent fertility clinics obstacles like constrained public investment and diversity in state regulations influence the adoption of donor egg IVF services in Canada. The escalating demand of patients for customized fertility treatments and the advent of boutique fertility clinics usher the assortment of the donor egg IVF (In-Vitro Fertilization) market in Canada.
Opportunities for Donor Egg IVF in Europe
| Countries | CAGR (2024 to 2034) |
|---|---|
| France | 7.50% |
| Germany | 7.30% |
| BENELUX | 7.20% |
| United Kingdom | 7.00% |
| Brazil | 6.80% |
| Russia | 6.70% |
Cultural perception toward parenthood and fertility treatments carves out the prospect of donor egg IVF (In-Vitro Fertilization) market in France. The adoption of donor eggs is enhancing, with amplifying awareness and affirmation of artificial reproduction methods in France. The regulatory regime in France delivers concise guidelines for donor egg IVF methods, warranting ethical and secure medical practices.
The patient support groups and advocacy organizations catering to Germany are vital since they provide a compassionate environment for people going through donor egg IVF and infertility issues. Fertility specialists have access to opportunities for professional growth and continuous medical education, guaranteeing that clinics sustain top-notch care while staying at the pinnacle of artificial reproduction advancements.
Donor egg IVF is one of the fertility treatments backed financially by the NHS in the United Kingdom. This makes sure that all qualified patients, regardless of their financial situation, have proper access to artificial human reproduction, broadening the adoption.
Informed consent and liberty for donors and recipients are put first by the United Kingdom’s regulatory framework, which assures transparent practices all along the donor egg IVF treatment. Education and community engagement programs assist people become aware of donor egg IVF and infertility, which minimizes the stigma and boosts the confidence to seek alternative treatment and support.
Opportunities in the Asia Pacific Industry
| Countries | CAGR (2024 to 2034) |
|---|---|
| China | 12.90% |
| India | 9.60% |
| Japan | 5.90% |
The demand for donor egg IVF is bolstered by cultural expectations for biological parenthood and family lineage, especially in regions where ancestral legacy is prioritized. The potential for donor egg IVF (In-Vitro Fertilization) market expansion is facilitated by government strategies like the relaxation of the one-child policy that tries to eradicate infertility issues.
Indian couples are actively on the hunt for donor egg IVF treatments, which is somewhat due to socioeconomic issues like postponed marriages and career-focused lifestyles, escalating the demand. An array of fertility clinics and establishments catering to medical tourism makes these services widely accessible in India, amplifying the donor egg IVF (In-Vitro Fertilization) market growth.
The demand for treatment for age-related infertility is thrust by Japan's senior population and declining birth rates. The cultural stigmas associated with infertility are briskly washing out, which results in escalation in the adoption of donor egg IVF treatments in Japan.
The donor egg IVF (In-Vitro Fertilization) market is shaped by various elements like technological advancements, regulations, demographic trends, and the presence of qualified medical care professionals. Key donor egg IVF service vendors are fertility clinics, hospitals, and specialized reproductive healthcare centers.
The donor egg in-vitro fertilization treatment providers with a broad network of clinics with high demand for artificial reproductive techniques provide a competitive edge. The reputation and success rates of clinics are crucial in luring patients.
The progress in technology is another catalyst of competition. Clinics investing money in advanced techniques, like embryo screening technologies and better cryopreservation methods, upskill themselves and entice a wider customer base looking for higher success rates.
Cost is another major factor in the market's competitive landscape, as affordability is crucial in the decision-making process of the patient. Clinics that provide competitive pricing or financial assistance programs like EMIs get the upper hand in clutching patients.
The donor egg IVF market is very competitive, with service providers contending to differentiate from each other with elements like global presence, innovation, regulatory infrastructure, affordability, and most importantly, adherence to ethical bylaws and patient security.
Noteworthy Observations
| Company | California Cryobank |
|---|---|
| Headquarter | United States |
| Recent Advancement |
|
| Company | ConceiveAbilities |
|---|---|
| Headquarter | United States |
| Recent Advancement |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The revenue size of donor egg IVF to attain a valuation US$ 3,347.10 million in 2024.
The demand for donor egg in-vitro fertilization (IVF) has the potential to seize an estimation of US$ 7,159.50 million by 2034.
The donor egg in-vitro fertilization sales revenue indicates to a CAGR of 7.90% through 2034.
From 2019 to 2023, the donor egg IVF market exhibited a 7.40% CAGR.
The fresh donor egg cycle sector is set to achieve a global market share of 70.10% in 2024.
The fertility clinics and IVF centers segment to possess a global market share of 64.50% in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Cycle Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Cycle Type, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Cycle Type, 2024 to 2034
5.3.1. Fresh Donor Egg Cycle
5.3.2. Frozen Donor Egg Cycle
5.4. Y-o-Y Growth Trend Analysis By Cycle Type, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Cycle Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034
6.3.1. Direct / Patient
6.3.2. Hospitals
6.3.3. Fertility Clinics & IVF Centres
6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Cycle Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Cycle Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Cycle Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Cycle Type
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Cycle Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Cycle Type
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Cycle Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Cycle Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Cycle Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Cycle Type
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Cycle Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Cycle Type
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Cycle Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Cycle Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2023
15.1.2.1. By Cycle Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2023
15.2.2.1. By Cycle Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2023
15.3.2.1. By Cycle Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2023
15.4.2.1. By Cycle Type
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2023
15.5.2.1. By Cycle Type
15.5.2.2. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2023
15.6.2.1. By Cycle Type
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2023
15.7.2.1. By Cycle Type
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2023
15.8.2.1. By Cycle Type
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2023
15.9.2.1. By Cycle Type
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2023
15.10.2.1. By Cycle Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2023
15.11.2.1. By Cycle Type
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2023
15.12.2.1. By Cycle Type
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2023
15.13.2.1. By Cycle Type
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2023
15.14.2.1. By Cycle Type
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2023
15.15.2.1. By Cycle Type
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2023
15.16.2.1. By Cycle Type
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2023
15.17.2.1. By Cycle Type
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2023
15.18.2.1. By Cycle Type
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2023
15.19.2.1. By Cycle Type
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2023
15.20.2.1. By Cycle Type
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2023
15.21.2.1. By Cycle Type
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2023
15.22.2.1. By Cycle Type
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2023
15.23.2.1. By Cycle Type
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Cycle Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. California Cryobank
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. ConceiveAbilities
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Center for Human Reproduction
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Growing Generations LLC
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Cryos International
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Fairfax EggBank
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. The World Egg Bank
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Global Donor Egg Bank
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. New Life Ukraine
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. First Egg Bank
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. MyEggBank
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. Ovobank
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Healthcare
March 2023
REP-GB-12785
330 pages
Explore Healthcare Insights
View Reports
Donor Egg IVF (In-Vitro Fertilization) Market
